SBIJI Innovation May 101 minAyala Pharmaceuticals Announces Pricing of Initial Public OfferingMay 7, 2020 Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeuti...
SBIJI Innovation Feb 121 minD-Fend solution The EnforceAir is the U.S. DIU's core RF system for integration into a C-UAS systemFeb 4, 2020 The EnforceAir is the U.S. DIU's core RF system for integration into a C-UAS system Read more
SBIJI Innovation Jan 121 minLogicBio Therapeutics Announces Submission of Investigational New Drug Application (IND) for LB-001 January 10, 2020 LogicBio Therapeutics Announces Submission of Investigational New Drug Application (IND) for LB-001 for Methylmalonic Acidemia (MMA) and Hig...
SBIJI Innovation Jan 121 minD-Fend solutions chosen to protect U.S. national securityDec 5, 2019 D-Fend solutions chosen to protect U.S. national security Read more
SBIJI Innovation Jan 121 minBiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX00Dec 2, 2019 BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin Read more
SBIJI Innovation Jan 121 minOrasis Pharmaceuticals Announces CSF-1 Eye Drop Successfully Met Primary Endpoint in Phase 2b ClinicOctober 10, 2019 Orasis Pharmaceuticals Announces CSF-1 Eye Drop Successfully Met Primary Endpoint in Phase 2b Clinical Study in Presbyopia Read more
